CG Oncology (CGON) Competitors $27.46 +0.64 (+2.39%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$26.64 -0.82 (-2.97%) As of 08:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CGON vs. ROIV, GRFS, RVMD, RYTM, LEGN, RGC, RNA, AXSM, ABVX, and NUVLShould you be buying CG Oncology stock or one of its competitors? The main competitors of CG Oncology include Roivant Sciences (ROIV), Grifols (GRFS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Regencell Bioscience (RGC), Avidity Biosciences (RNA), Axsome Therapeutics (AXSM), Abivax (ABVX), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. CG Oncology vs. Its Competitors Roivant Sciences Grifols Revolution Medicines Rhythm Pharmaceuticals Legend Biotech Regencell Bioscience Avidity Biosciences Axsome Therapeutics Abivax Nuvalent CG Oncology (NASDAQ:CGON) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment. Do analysts recommend CGON or ROIV? CG Oncology currently has a consensus price target of $54.30, indicating a potential upside of 97.74%. Roivant Sciences has a consensus price target of $16.38, indicating a potential upside of 32.16%. Given CG Oncology's higher probable upside, equities analysts plainly believe CG Oncology is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CG Oncology 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.92Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.20 Does the media prefer CGON or ROIV? In the previous week, Roivant Sciences had 4 more articles in the media than CG Oncology. MarketBeat recorded 10 mentions for Roivant Sciences and 6 mentions for CG Oncology. Roivant Sciences' average media sentiment score of 1.58 beat CG Oncology's score of 1.47 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CG Oncology 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better earnings & valuation, CGON or ROIV? CG Oncology has higher earnings, but lower revenue than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than CG Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCG Oncology$1.14M1,836.69-$88.04M-$1.77-15.51Roivant Sciences$29.05M291.25-$171.98M-$0.70-17.70 Is CGON or ROIV more profitable? Roivant Sciences has a net margin of -2,111.79% compared to CG Oncology's net margin of -15,945.17%. Roivant Sciences' return on equity of -15.90% beat CG Oncology's return on equity.Company Net Margins Return on Equity Return on Assets CG Oncology-15,945.17% -19.37% -18.72% Roivant Sciences -2,111.79%-15.90%-14.95% Do institutionals and insiders hold more shares of CGON or ROIV? 26.6% of CG Oncology shares are held by institutional investors. Comparatively, 64.8% of Roivant Sciences shares are held by institutional investors. 10.8% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, CGON or ROIV? CG Oncology has a beta of 0.87, suggesting that its share price is 13% less volatile than the S&P 500. Comparatively, Roivant Sciences has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. SummaryRoivant Sciences beats CG Oncology on 12 of the 17 factors compared between the two stocks. Get CG Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CGON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CGON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGON vs. The Competition Export to ExcelMetricCG OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.04B$3.10B$5.74B$9.77BDividend YieldN/A2.28%6.66%4.48%P/E Ratio-15.5120.8683.2226.39Price / Sales1,836.69396.84536.63110.01Price / CashN/A43.5325.7028.92Price / Book3.128.1011.046.58Net Income-$88.04M-$53.35M$3.28B$265.84M7 Day Performance3.70%-0.29%-0.17%-0.26%1 Month Performance4.37%9.18%8.34%5.82%1 Year Performance-22.36%10.11%53.90%22.47% CG Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGONCG Oncology2.8822 of 5 stars$27.46+2.4%$54.30+97.7%-25.5%$2.04B$1.14M-15.5161Positive NewsROIVRoivant Sciences3.0514 of 5 stars$11.64-2.3%$16.50+41.8%+1.3%$8.14B$29.05M-16.63860News CoveragePositive NewsAnalyst ForecastGRFSGrifols3.9358 of 5 stars$9.82-3.3%$10.30+4.9%+3.6%$6.99B$7.81B8.3923,822News CoveragePositive NewsGap DownRVMDRevolution Medicines4.478 of 5 stars$35.67-3.6%$69.92+96.0%-7.3%$6.92BN/A-7.93250News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.3046 of 5 stars$99.20-3.9%$101.57+2.4%+120.4%$6.86B$130.13M-32.96140Positive NewsLEGNLegend Biotech3.5388 of 5 stars$34.60-2.7%$73.00+111.0%-40.5%$6.53B$627.24M-39.322,609RGCRegencell Bioscience0.1883 of 5 stars$12.28-4.1%N/AN/A$6.33BN/A0.0010RNAAvidity Biosciences3.1969 of 5 stars$45.27-2.3%$67.00+48.0%+7.3%$5.96B$10.90M-12.72190Positive NewsAXSMAxsome Therapeutics4.7654 of 5 stars$116.31-1.9%$178.00+53.0%+38.9%$5.91B$385.69M-22.94380Positive NewsAnalyst ForecastInsider TradeABVXAbivax3.2603 of 5 stars$77.46+0.2%$92.33+19.2%+545.1%$5.84BN/A0.0061News CoveragePositive NewsShort Interest ↓NUVLNuvalent3.2305 of 5 stars$74.05-2.7%$118.91+60.6%-9.7%$5.49BN/A-15.1140News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Roivant Sciences Competitors Grifols Competitors Revolution Medicines Competitors Rhythm Pharmaceuticals Competitors Legend Biotech Competitors Regencell Bioscience Competitors Avidity Biosciences Competitors Axsome Therapeutics Competitors Abivax Competitors Nuvalent Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CGON) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGON Stock Alerts